EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY 4.0

Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report

E Rossetti iD, A Cappoli, R Labbadia, G Leone, F Chiusolo, F Tortora, D Martinelli, M Marano

Journal of Clinical Apheresis · 2025-06 · 40 (3)

DOI: 10.1002/jca.70032 ↗

At a glance

Fallbericht in Journal of Clinical Apheresis, published online on 2025-05-22. Written by E Rossetti and 7 co-authors. Institution: Pediatric Intensive Care Unit, Anaesthesia and Intensive Care Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Major MEDLINE topics: Anemia, Sickle Cell, Hepatic Encephalopathy, Sepsis, Triazoles. Cited 2 times so far (Crossref); 10 references. The full text is freely available (open access, CC BY 4.0). Funded by: Italian Ministry of Health with 'Current Research Funds'.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

This report details a rare pediatric case of hyperammonemic encephalopathy caused by the oral iron chelating drug deferasirox (DFR) in a septic patient. It is our contention that this study lends support to the existing literature, as it describes the case of a 15‐year‐old female patient with a history of sickle‐cell disease who presented with a fever and vomiting, rapid development of sleepiness, consciousness disturbances, medium mydriasis, neck stiffness, and trismus with seizure. Her Glasgow Coma Scale (GCS) score was 5. Laboratory tests revealed an increase in creatinine, metabolic acidosis, hyperammonemia, high cerebrospinal fluid (CSF) glutamine levels, alterations in coagulation and in liver function, rising inflammatory markers, cerebral oedema on brain Computerized Tomography (CT) scan, 10^6 copies/ml of Methicillin‐Resistant Staphylococcus Aureus (MRSA) in pulmonary swab film array, and elevated DFR blood level. The treatment plan involved the early cessation of DFR, the correction of acidosis, mechanical ventilation, mannitol and bioarginine, vasoactive drug, antibiotics, and supportive care with continuous veno‐venous hemodiafiltration (CVVHDF) for hyperammonemia and therapeutic plasma exchange (TPE) for a high CSF glutamine level resulting from cytotoxic encephalopathy. The patient successfully overcame the multiorgan failure, with no permanent neurologic complications. It is our opinion that healthcare providers and family caregivers of patients with chronic disease may be particularly attuned to the emergence of any sign or symptom, and thus well positioned to take prompt action to avert life‐threatening clinical deterioration due to rising DFR levels. It is recommended that critical care providers commence extracorporeal blood purification therapies (EBPT) at the earliest opportunity, taking care to adapt the technique to the specific needs of the patient and to avoid the potential for fatal neurological complications.

Subjects

MeSH terms (MEDLINE)

Anemia, Sickle CellHepatic EncephalopathySepsisTriazolesBenzoatesIron Chelating AgentsHemodiafiltrationHumansFemaleDeferasiroxAdolescentHyperammonemiaPlasma Exchange

Author keywords

continuous renal replacement therapydeferasiroxencephalopathyhyperammonemialiver failureplasma exchangesepsis

Substances

DeferasiroxTriazolesBenzoatesIron Chelating Agents

Authors and institutions

  • Pediatric Intensive Care Unit, Anaesthesia and Intensive Care Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Unit of Nephrology and Dialysis, Division of Pediatric Subspecialties, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Unit of Transfusion Medicine, Division of Diagnostic and Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Division of Metabolism, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Area Rossa Division, Pediatric Poison Control Center, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

ORCID profiles: E Rossetti

Funding

  • Italian Ministry of Health with 'Current Research Funds'

Cite

APA

Rossetti, E., Cappoli, A., Labbadia, R., Leone, G., Chiusolo, F., Tortora, F., Martinelli, D., & Marano, M. (2025). Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report. Journal of Clinical Apheresis, 40(3). https://doi.org/10.1002/jca.70032

Vancouver

Rossetti E, Cappoli A, Labbadia R, Leone G, Chiusolo F, Tortora F, et al. Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report. Journal of Clinical Apheresis. 2025;40(3). doi:10.1002/jca.70032

BibTeX
@article{Rossetti2025,
  author = {Rossetti, E and Cappoli, A and Labbadia, R and Leone, G and Chiusolo, F and Tortora, F and Martinelli, D and Marano, M},
  title = {Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report},
  journal = {Journal of Clinical Apheresis},
  year = {2025},
  volume = {40},
  number = {3},
  doi = {10.1002/jca.70032}
}
Start for free →